Brown Brothers Harriman & Co. Has $849,000 Stake in Stericycle, Inc. (NASDAQ:SRCL)

Brown Brothers Harriman & Co. lowered its holdings in Stericycle, Inc. (NASDAQ:SRCL) by 17.9% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 14,605 shares of the business services provider’s stock after selling 3,187 shares during the period. Brown Brothers Harriman & Co.’s holdings in Stericycle were worth $849,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also added to or reduced their stakes in SRCL. Victory Capital Management Inc. grew its position in Stericycle by 19.4% in the fourth quarter. Victory Capital Management Inc. now owns 20,487 shares of the business services provider’s stock valued at $1,015,000 after purchasing an additional 3,334 shares in the last quarter. Private Advisor Group LLC grew its position in Stericycle by 8.6% in the fourth quarter. Private Advisor Group LLC now owns 5,788 shares of the business services provider’s stock valued at $287,000 after purchasing an additional 459 shares in the last quarter. Principal Securities Inc. bought a new position in Stericycle in the fourth quarter valued at $41,000. Dimensional Fund Advisors LP grew its position in Stericycle by 10.8% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,971,719 shares of the business services provider’s stock valued at $97,720,000 after purchasing an additional 192,045 shares in the last quarter. Finally, Vanguard Personalized Indexing Management LLC grew its position in Stericycle by 14.2% in the fourth quarter. Vanguard Personalized Indexing Management LLC now owns 5,653 shares of the business services provider’s stock valued at $280,000 after purchasing an additional 705 shares in the last quarter. Institutional investors own 98.82% of the company’s stock.

Wall Street Analyst Weigh In

SRCL has been the subject of a number of analyst reports. Truist Financial raised their target price on shares of Stericycle from $50.00 to $62.00 and gave the company a “hold” rating in a research report on Tuesday, June 4th. Royal Bank of Canada reissued a “sector perform” rating and issued a $62.00 price objective (down previously from $69.00) on shares of Stericycle in a research report on Tuesday, June 4th. Keefe, Bruyette & Woods lifted their price objective on shares of Stericycle from $135.00 to $142.00 and gave the company an “outperform” rating in a research report on Tuesday, June 4th. Finally, StockNews.com started coverage on shares of Stericycle in a research report on Tuesday. They issued a “hold” rating for the company. One research analyst has rated the stock with a sell rating, four have issued a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $74.00.

Stericycle Stock Performance

Shares of SRCL stock opened at $61.68 on Wednesday. The company has a market capitalization of $5.73 billion, a price-to-earnings ratio of -280.36, a PEG ratio of 3.37 and a beta of 1.11. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.13 and a current ratio of 1.13. The company has a 50-day simple moving average of $59.06 and a 200 day simple moving average of $54.62. Stericycle, Inc. has a 52 week low of $37.78 and a 52 week high of $61.77.

Stericycle (NASDAQ:SRCL) last announced its earnings results on Thursday, July 25th. The business services provider reported $0.61 EPS for the quarter, topping the consensus estimate of $0.57 by $0.04. The business had revenue of $661.60 million during the quarter, compared to the consensus estimate of $672.07 million. Stericycle had a net margin of 1.37% and a return on equity of 7.94%. On average, sell-side analysts predict that Stericycle, Inc. will post 2.29 earnings per share for the current year.

Stericycle Company Profile

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.